Aurion Biotech logo

Aurion Biotech

aurionbiotech.com

Aurion Biotech develops regenerative cell therapies for the treatment of blindness and vision loss, with a lead program focused on corneal endothelial cell therapy for patients with corneal endothelial disease. Its therapies aim to restore vision by replacing lost or dysfunctional endothelial cells using human donor cells, providing a less invasive alternative to traditional corneal transplantation. The organization’s mission is to expand global access to advanced ophthalmic care and address significant unmet needs in treating blindness.

Facts

HQ
Seattle
Sectors
Biotechnology
Founded
2022
Employees
116
Stage
Clinical stage
Members see funding amounts.
.

Is this your organization? Claim it

Recent coverage

Front-page news, podcasts and videos about Aurion Biotech

See all 6

Gennev Founder Jill Angelo Steps Down After Acquisition; Aurion Biotech CEO Replaced Following Alcon Majority Stake; Temporal Adds New Leadership

Jill Angelo, founder and CEO of menopause startup Gennev, stepped down following its acquisition by Unified Women’s Healthcare, while Aurion Biotech replaced CEO Greg Kunst with Arnaud Lacoste after Alcon acquired a majority stake. Temporal also announced leadership additions with Jim Cyb as president and Sahir Azam as an independent board member.

People

  • Arnaud Lacoste Executive, Executive Officer, CEO and Chief Scientific Officer
  • Greg Kunst Executive, Executive Officer, Director, CEO

Online

Questions about Aurion Biotech

What is Aurion Biotech?

Aurion Biotech is a startup that develops regenerative cell therapies to treat blindness and vision loss, with a lead program focused on corneal endothelial disease. Aurion Biotech is based in Seattle.

What has Aurion Biotech been in the news for?

GeekWire reported in April 2025 that Aurion Biotech’s CEO was replaced.

Who are the people behind Aurion Biotech?

Arnaud Lacoste is listed as CEO and chief scientific officer at Aurion Biotech. Greg Kunst is listed as CEO and director at Aurion Biotech.

Who invested in Aurion Biotech, and how much has it raised?

Members of Seattle Flow see Aurion Biotech's funding rounds, amounts and investors on its Funding tab. Joining is free.

Where is Aurion Biotech based?

Aurion Biotech is based in Seattle.

When was Aurion Biotech founded?

Aurion Biotech was founded in 2022.